Histologix provides 100% QC for GLP and non-GLP studies in a range of species from early discovery and regulatory preclinical toxicology through to clinical trials.
Histologix provides specialist IHC, IF and ISH services on behalf of its clients, including target validation and distribution in many therapeutic areas.
Digital Pathology & Image Analysis
Digital Image Analysis performed by in-house specialists using the HALO™ image analysis software. Semi-quantitative endpoints, with interpretation and recommendations adds value to your studies.
A range of validated immune biomarker assays which can be used to assess immune infiltrates within the tumour micro-environment. Assessing IO biomarkers with image analysis helps in predicting the efficacy of immuno-therapeutics.
Therapeutic molecular classes must undergo regulatory screening in human tissue as part of any preclinical safety assessment in line with FDA, EU and Japanese MAFF regulations. Histologix has 100+ years of combined experience.
Using the GCP Accreditation and HTA licences, Histologix performs analysis upon tissue samples from clinical trials in Ph0, Ph1 and Ph2 trials. We assess predictive and prognostic biomarkers, and develop companion diagnostics.